Historical PSAs - Prescription Drug Campaign

Historical PSAs - Tamper Resistant Packaging

FDA's Public Meeting on Food Allergen Thresholds - 02/18/2026

Historical PSAs - Do Not Mix Drugs

Medical Device Quality Management System Regulation Design and Development

FDA Expert Panel on Testosterone Replacement Therapy for Men

FDA Grand Rounds - Advancing Real World Evidence in FDA Regulatory Decision Making

FDA Grand Rounds - Antibody Glycosylation Insights for High Quality Biotherapeutics

FDA-USP-AAM | D1S3 - Industry’s Engagement in USP’s Standards-Setting Process

FDA Celebrates 120 Years

Conversations on Cancer – Perspectives on Cancer Care Decision-Making Among Older Adults

Historical PSAs - Take a Look - Commissioner David Kessler

FDA-USP-AAM | D1S1 – FDA's Participation in USP-NF Revision Process – Challenges and Solutions

FDA Grand Rounds - Adopting Large Language Models for Regulatory Review

January 22, 2026: Tobacco Products Scientific Advisory Committee Meeting

FDA Grand Rounds - Statistical Considerations for Drug Development in Rare Disease

Historical PSAs - A Child's World is Full of Pretty Poisons

FDA Grand Rounds - Postmarket Regulation of Cosmetic Products: The Who, What, When, Why, and How

FDA-USP-AAM | D1S4 – Q&A Discussion Panel

FDA Grand Rounds - Forensic Proteomics Applied to FDA Regulated Products

Public Meeting: Reauthorization of the Biosimilar User Fee Act